Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Sep;19(9):1030-5.
doi: 10.1016/s0046-8177(88)80082-0.

Observer variation in histologic classification of malignant and borderline ovarian tumors

Affiliations

Observer variation in histologic classification of malignant and borderline ovarian tumors

H Stalsberg et al. Hum Pathol. 1988 Sep.

Abstract

Eight hundred sixty-nine primary malignant or borderline ovarian tumors reported to the Norwegian Cancer Registry were reviewed. The histologic slides were randomly distributed to six observers and classified according to the World Health Organization classification of ovarian tumors. By rotation of slides, each tumor was successively reviewed by three observers. Each observer was given approximately 40 duplicates of slides he or she had typed before, mixed in with the slides for the third review. A contracted version of the classification with 27 entries was used in the analysis. Mean intraobserver reproducibility was 62% (kappa, 0.53), varying from 50% to 75% (kappa, 0.34 to 0.70) for the individual observers. The mean rate of agreement between two observers was 56% (kappa, 0.46), varying from 46% to 65% for the individual pairs of observers. The rate of full agreement among three observers was 41%. The most common disagreements were between different specific types of carcinoma, between undifferentiated and differentiated carcinoma, between borderline and malignant tumors, between unclassified and classified carcinoma, and between mixed and pure types of carcinoma. Very low reproducibility was obtained for mixed and unclassified carcinoma.

PubMed Disclaimer

Similar articles

Cited by

  • Low-grade serous ovarian cancer: a unique disease.
    Schmeler KM, Gershenson DM. Schmeler KM, et al. Curr Oncol Rep. 2008 Nov;10(6):519-23. doi: 10.1007/s11912-008-0078-8. Curr Oncol Rep. 2008. PMID: 18928667 Review.
  • Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.
    Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group; Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP, Cramer DW, Vitonis AF, Bandera EV, Olson SH, Rodriguez-Rodriguez L, King M, Brinton LA, Yang H, Garcia-Closas M, Lissowska J, Anton-Culver H, Ziogas A, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Webb PM; Ovarian Cancer Association Consortium. Olsen CM, et al. Endocr Relat Cancer. 2013 Mar 22;20(2):251-62. doi: 10.1530/ERC-12-0395. Print 2013 Apr. Endocr Relat Cancer. 2013. PMID: 23404857 Free PMC article.
  • BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study.
    Bjørge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Tropé CG, Dørum A. Bjørge T, et al. Br J Cancer. 2004 Nov 15;91(10):1829-34. doi: 10.1038/sj.bjc.6602199. Br J Cancer. 2004. PMID: 15477862 Free PMC article.
  • Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.
    Bodurka DC, Deavers MT, Tian C, Sun CC, Malpica A, Coleman RL, Lu KH, Sood AK, Birrer MJ, Ozols R, Baergen R, Emerson RE, Steinhoff M, Behmaram B, Rasty G, Gershenson DM. Bodurka DC, et al. Cancer. 2012 Jun 15;118(12):3087-94. doi: 10.1002/cncr.26618. Epub 2011 Nov 9. Cancer. 2012. PMID: 22072418 Free PMC article.
  • Survival in women with grade 1 serous ovarian carcinoma.
    Nickles Fader A, Java J, Ueda S, Bristow RE, Armstrong DK, Bookman MA, Gershenson DM; Gynecologic Oncology Group (GOG)*. Nickles Fader A, et al. Obstet Gynecol. 2013 Aug;122(2 Pt 1):225-232. doi: 10.1097/AOG.0b013e31829ce7ec. Obstet Gynecol. 2013. PMID: 23969788 Free PMC article.

Publication types

LinkOut - more resources